The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on available information, the cause of the reported rash and allergic reaction could not be determined.The reported patient effect of hypersensitivity/allergic reaction, as listed in the mitraclip system instructions for use, is a known possible complication associated with mitraclip procedures.The reported serious injury/ illness/ impairment was a result of case-specific circumstances.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
|
It was reported that on (b)(6) 2023, a mitraclip procedure was performed to treat functional mitral regurgitation (mr) with a grade of 4.A mitraclip xtw was implanted without issues, reducing the mr to a grade of 1-2.On january 4, 2024, three months after the procedure, the patient developed a rash and pustules on the body.There are several known allergies, but none were due to nickel, cobalt, or titanium.It was noted that the previous implanted clip was stable on both leaflets.There are no allegations of device malfunction.
|